ARDS logo

Aridis Pharmaceuticals (ARDS) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$4.88 M
-$13.22 M-73.06%

December 31, 2022


Summary


Performance

ARDS Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARDSbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$35.00 K
+$16.00 K+84.21%

September 30, 2023


Summary


Performance

ARDS Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARDSbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ARDS Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-73.1%+84.2%
3 y3 years-76.7%-99.4%
5 y5 years-80.6%-99.8%

ARDS Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-73.1%at low-99.8%+84.2%
5 y5-year-76.7%at low-99.8%+84.2%
alltimeall time-80.6%at low-99.9%+84.2%

Aridis Pharmaceuticals Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2023
-
$35.00 K(+84.2%)
Jun 2023
-
$19.00 K(-98.6%)
Mar 2023
-
$1.32 M(-72.9%)
Dec 2022
$4.88 M(-73.1%)
$4.88 M(+158.5%)
Sep 2022
-
$1.89 M(-70.1%)
Jun 2022
-
$6.32 M(-49.4%)
Mar 2022
-
$12.47 M(-31.1%)
Dec 2021
$18.10 M(+119.8%)
$18.10 M(-0.7%)
Sep 2021
-
$18.22 M(+407.3%)
Jun 2021
-
$3.59 M(-65.7%)
Mar 2021
-
$10.47 M(+27.2%)
Dec 2020
$8.23 M
$8.23 M(+32.5%)
DateAnnualQuarterly
Sep 2020
-
$6.21 M(-47.4%)
Jun 2020
-
$11.81 M(-27.6%)
Mar 2020
-
$16.32 M(-21.9%)
Dec 2019
$20.90 M(-13.8%)
$20.90 M(+20.6%)
Sep 2019
-
$17.33 M(+103.4%)
Jun 2019
-
$8.52 M(-47.8%)
Mar 2019
-
$16.31 M(-32.7%)
Dec 2018
$24.24 M(-3.4%)
$24.24 M(-28.9%)
Sep 2018
-
$34.08 M(+153.0%)
Jun 2018
-
$13.47 M(-33.9%)
Mar 2018
-
$20.39 M(-18.8%)
Dec 2017
$25.10 M(+12.6%)
$25.10 M
Dec 2016
$22.29 M
-

FAQ

  • What is Aridis Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Aridis Pharmaceuticals quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

What is Aridis Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of ARDS is $4.88 M

What is the all time high annual cash & cash equivalents for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high annual cash & cash equivalents is $25.10 M

What is Aridis Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, ARDS annual cash & cash equivalents has changed by -$13.22 M (-73.06%)

What is Aridis Pharmaceuticals quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of ARDS is $35.00 K

What is the all time high quarterly cash and cash equivalents for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high quarterly cash and cash equivalents is $34.08 M

What is Aridis Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

Over the past year, ARDS quarterly cash and cash equivalents has changed by +$16.00 K (+84.21%)